U.S. markets closed
  • S&P Futures

    3,449.50
    +17.25 (+0.50%)
     
  • Dow Futures

    28,309.00
    +127.00 (+0.45%)
     
  • Nasdaq Futures

    11,730.00
    +69.25 (+0.59%)
     
  • Russell 2000 Futures

    1,621.50
    +6.70 (+0.41%)
     
  • Crude Oil

    41.45
    -0.25 (-0.60%)
     
  • Gold

    1,916.20
    +0.80 (+0.04%)
     
  • Silver

    24.97
    -0.01 (-0.04%)
     
  • EUR/USD

    1.1839
    +0.0010 (+0.08%)
     
  • 10-Yr Bond

    0.7970
    +0.0360 (+4.73%)
     
  • Vix

    29.35
    +0.17 (+0.58%)
     
  • GBP/USD

    1.2960
    +0.0013 (+0.10%)
     
  • USD/JPY

    105.4600
    -0.0100 (-0.01%)
     
  • BTC-USD

    11,961.38
    +904.37 (+8.18%)
     
  • CMC Crypto 200

    240.39
    +1.47 (+0.62%)
     
  • FTSE 100

    5,889.22
    +4.57 (+0.08%)
     
  • Nikkei 225

    23,691.45
    +124.41 (+0.53%)
     

Why Hologic, Inc. (NASDAQ:HOLX) Looks Like A Quality Company

Simply Wall St
·4 mins read

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it is important. By way of learning-by-doing, we'll look at ROE to gain a better understanding of Hologic, Inc. (NASDAQ:HOLX).

Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. In simpler terms, it measures the profitability of a company in relation to shareholder's equity.

View our latest analysis for Hologic

How To Calculate Return On Equity?

Return on equity can be calculated by using the formula:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

So, based on the above formula, the ROE for Hologic is:

22% = US$451m ÷ US$2.1b (Based on the trailing twelve months to March 2020).

The 'return' is the profit over the last twelve months. So, this means that for every $1 of its shareholder's investments, the company generates a profit of $0.22.

Does Hologic Have A Good ROE?

Arguably the easiest way to assess company's ROE is to compare it with the average in its industry. The limitation of this approach is that some companies are quite different from others, even within the same industry classification. As is clear from the image below, Hologic has a better ROE than the average (11%) in the Medical Equipment industry.

roe
roe

That is a good sign. However, bear in mind that a high ROE doesn’t necessarily indicate efficient profit generation. Aside from changes in net income, a high ROE can also be the outcome of high debt relative to equity, which indicates risk. Our risks dashboardshould have the 5 risks we have identified for Hologic.

The Importance Of Debt To Return On Equity

Most companies need money -- from somewhere -- to grow their profits. The cash for investment can come from prior year profits (retained earnings), issuing new shares, or borrowing. In the first and second cases, the ROE will reflect this use of cash for investment in the business. In the latter case, the debt required for growth will boost returns, but will not impact the shareholders' equity. That will make the ROE look better than if no debt was used.

Hologic's Debt And Its 22% ROE

Hologic clearly uses a high amount of debt to boost returns, as it has a debt to equity ratio of 1.71. There's no doubt its ROE is decent, but the very high debt the company carries is not too exciting to see. Debt increases risk and reduces options for the company in the future, so you generally want to see some good returns from using it.

Conclusion

Return on equity is useful for comparing the quality of different businesses. A company that can achieve a high return on equity without debt could be considered a high quality business. If two companies have the same ROE, then I would generally prefer the one with less debt.

But when a business is high quality, the market often bids it up to a price that reflects this. The rate at which profits are likely to grow, relative to the expectations of profit growth reflected in the current price, must be considered, too. So I think it may be worth checking this free report on analyst forecasts for the company.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.